| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/22/2011 | CN102100713A Method for preparing water-soluble marigold yellow pigment microcapsules |
| 06/22/2011 | CN102100702A Method for covering stinking smells of animal medicines |
| 06/22/2011 | CN102100686A Medicinal composition containing ibuprofen and arginine and preparation method and application thereof |
| 06/22/2011 | CN102100683A Slow-soluble external contraceptive membrane |
| 06/22/2011 | CN102100682A Slow release long-acting rasagiline transdermal patch with high bioavailability and preparation method thereof |
| 06/22/2011 | CN102100680A Benazepril hydrochloride pulse-released tablet and preparation method thereof |
| 06/22/2011 | CN102100679A Carprofen matrix tablets |
| 06/22/2011 | CN102100677A Entecavir dispersible tablets and preparation method thereof |
| 06/22/2011 | CN102100676A Vinpocetine orally disintegrating tablets |
| 06/22/2011 | CN102100675A Ofloxacin otic pill for dogs and cats |
| 06/22/2011 | CN102100673A Method for improving direct tabletting content uniformity of medicines with low loading rate |
| 06/22/2011 | CN102100672A Vascular endothelial growth factor chitosan microsphere and application thereof |
| 06/22/2011 | CN102100671A Method for preparing esomeprazole enteric capsules |
| 06/22/2011 | CN102100670A Poly(lactic-co-glycolic acid) nanoparticle, preparation method and application thereof |
| 06/22/2011 | CN102100669A Immunity liposome, and preparation method and application thereof |
| 06/22/2011 | CN102100668A Advanced fatty acid derivative micro emulsion and preparation method and application thereof |
| 06/22/2011 | CN102100667A Method for stabilizing tegafur in aqueous solution |
| 06/22/2011 | CN102100666A New moxifloxacin hydrochloride injection |
| 06/22/2011 | CN102100663A Method for preparing pH sensitive in-situ gel nano slow-release eye drop |
| 06/22/2011 | CN102100660A Oral solid preparation containing venlafaxine hydrochloride and preparation method thereof |
| 06/22/2011 | CN102100354A Process for refining edible mushroom agaric gel |
| 06/22/2011 | CN101829121B Hemsleyadin sustained-release preparation |
| 06/22/2011 | CN101773483B Preparation method of water-insoluble drug microcapsule |
| 06/22/2011 | CN101756915B Tirofiban hydrochloride lyophilized powder injection and preparation method thereof |
| 06/22/2011 | CN101716156B Ubenimex dispersive tablet composition |
| 06/22/2011 | CN101716150B Acehytisine freeze-drying emulsion and reparation method thereof |
| 06/22/2011 | CN101708157B Isosorbide mononitrate sodium chloride injection |
| 06/22/2011 | CN101703472B Granulating coated slow release product of cysteamine hydrochloride and preparation method thereof |
| 06/22/2011 | CN101695475B Ozagrel sodium injection and preparation method thereof |
| 06/22/2011 | CN101670107B Multifunctional nuclear shell structure drug carrier material and preparation method thereof |
| 06/22/2011 | CN101669904B Epoprostanol lipid nanoparticle and preparation method thereof |
| 06/22/2011 | CN101632835B Preparation method of concentrated pills |
| 06/22/2011 | CN101623251B Gynecological antibacterial gel bionic propellant |
| 06/22/2011 | CN101618222B Anethol trithione and phospholipid compound and preparation method thereof |
| 06/22/2011 | CN101606914B Cefuroxime axetil tablet preparation suitable for direct powder compression |
| 06/22/2011 | CN101591444B Method for preparing laminar large composite vesicles from acrylamide and acrylic acid copolymer |
| 06/22/2011 | CN101518652B Preparation method of toltrazuril-cyclodextrin inclusion compound |
| 06/22/2011 | CN101491578B Cocklebur fruit drop-pills for treating rhinitis and preparation method thereof |
| 06/22/2011 | CN101474154B 4-(1-phenethyl)-1,3-dihydroxy benzene liposome and preparation method thereof |
| 06/22/2011 | CN101420937B Method for producing extended release tablet |
| 06/22/2011 | CN101370493B Hydronol preparation |
| 06/22/2011 | CN101365432B Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 06/22/2011 | CN101301491B Composite bracket made of multialdehyde sodium alginate crosslinked calcium polyphosphate/chitosan and preparation and use thereof |
| 06/22/2011 | CN101293963B Amphiprotic co-continuous polymer network, preparation method and application thereof |
| 06/22/2011 | CN101270168B Hyaluronic acid stem grafting polyethylene imine copolymer, preparing method and application as genophore |
| 06/22/2011 | CN101259161B Production technology of cream for treating toothache and odontitis |
| 06/22/2011 | CN101239189B Tenofovir, adefovir and intelligent polymer conjugates and preparation and use thereof |
| 06/22/2011 | CN101239182B Calcium phosphate delivery vehicles for osteoinductive proteins |
| 06/22/2011 | CN101229388B Stanching material (spray, membrane) based on Chinese herbal medicine and preparing method thereof |
| 06/22/2011 | CN101130061B Segmented intestine targeted drug feeding preparation of myocardium protein polypeptide and method of producing the same |
| 06/22/2011 | CN101084885B Two sustained-release preparations containing cinnamic acid for preventing coxsackie virus and preparation technology thereof |
| 06/22/2011 | CN101062374B Method for preparing Chinese traditional combination capsule for treating cancer and the product thereof |
| 06/22/2011 | CN101011354B Asarone submicron emulsion and its preparation method |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means |
| 06/21/2011 | US7964579 Compositions and methods for topical delivery of oligonucleotides |
| 06/21/2011 | US7964578 Conjugates and compositions for cellular delivery |
| 06/21/2011 | US7964568 Synthesis of high molecular weight iron-saccharidic complexes |
| 06/21/2011 | US7964567 Monomethylvaline compounds capable of conjugation to ligands |
| 06/21/2011 | US7964566 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases |
| 06/21/2011 | US7964557 Administering adiponectin; inhibitory effect of adiponectin on choroidal angiogenesis or choroidal neovascularization |
| 06/21/2011 | US7964224 Process for extraction and standardization of pharmaceutical quality tinctures and extracts from herbal products |
| 06/21/2011 | US7964220 Method for treating a mammal by administration of a compound having the ability to release CO |
| 06/21/2011 | US7964217 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 06/21/2011 | US7964216 Orally administering to a patient a spaced drug delivery system, wherein first therapeutically active agent is released immediately and second therapeutically active agent is released as a pulse at predetermined time after administration |
| 06/21/2011 | US7964181 Amino acid surrogates for peptidic constructs |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2602281C Gynecological drugs encapsulated in sodium alginate microspheres for use in embolotherapy |
| 06/21/2011 | CA2546064C Percutaneous absorption type cerebral protective agent |
| 06/21/2011 | CA2499273C Inhalation compositions |
| 06/21/2011 | CA2492775C Polyalkylene glycol acid additives |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2465641C Phenoxy amine compounds and compositions for delivering active agents |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2435681C Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 06/21/2011 | CA2430934C A method of producing sustained-release preparations of a bioactive substance using high-pressure gas |
| 06/21/2011 | CA2396796C Stabilized medicinal aerosol particulate formulations |
| 06/21/2011 | CA2396785C A medicinal aerosol formulation |
| 06/21/2011 | CA2370143C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2286177C Composition for gene transfer into cells |
| 06/21/2011 | CA2203857C Microparticles for delivery of nucleic acid |
| 06/16/2011 | WO2011072290A2 Targeted dendrimer-drug conjugates |
| 06/16/2011 | WO2011072218A2 Stable formulations for lyophilizing therapeutic particles |
| 06/16/2011 | WO2011072208A1 Ph sensitive compounds in taste masking within oral thin film strips |
| 06/16/2011 | WO2011072103A2 Glycerine based jelly compositions |
| 06/16/2011 | WO2011072069A2 Gastric retentive pharmaceutical compositions for extended release of polypeptides |
| 06/16/2011 | WO2011071970A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| 06/16/2011 | WO2011071684A1 Oral rehydration solutions comprising dextrose |
| 06/16/2011 | WO2011071620A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| 06/16/2011 | WO2011071139A1 Dry-coated orally disintegrating tablet |
| 06/16/2011 | WO2011070125A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/16/2011 | WO2011069484A2 Dermal, antimicrobial foot cream |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2011036560A3 Glycoconjugate compositions and methods for treatment of hiv |
| 06/16/2011 | WO2011031476A3 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 06/16/2011 | WO2011029028A9 Targeted delivery using tissue-specific peptidomimetic ligands |
| 06/16/2011 | WO2011022056A3 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 06/16/2011 | WO2011019940A3 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use |
| 06/16/2011 | WO2011017346A3 Fast-acting naproxen composition with reduced gastrointestinal effects |